Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2004-02-06
2008-10-21
Lewis, Patrick T (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S004100
Reexamination Certificate
active
07439232
ABSTRACT:
There is provided a heteroaryl 5-thio-β-D-glucopyranoside compound of the following formula, which has an inhibitory effect on SGLT2 activity, or a pharmaceutically acceptable salt thereof or a hydrate thereof. There is also provided a pharmaceutical preparation, particularly a prophylactic or therapeutic agent for diabetes, diabetes-related diseases or diabetic complications, which comprises such a compound as an active ingredient.
REFERENCES:
patent: 2004/0006025 (2004-01-01), Ohsumi et al.
patent: 2004/0138143 (2004-07-01), Glombik et al.
patent: 2005/0049203 (2005-03-01), Nishimura et al.
patent: 1 213 296 (2002-06-01), None
patent: 1 364 958 (2003-11-01), None
patent: WO 01/16147 (2001-03-01), None
patent: WO 01/74834 (2001-10-01), None
patent: WO 02/36602 (2002-05-01), None
patent: WO 02/068440 (2002-09-01), None
patent: WO 03/000712 (2003-01-01), None
patent: WO 2004/007517 (2004-01-01), None
Sakaguchi, et al., “Potential Radiosensitizing Agents. 4.2-Nitroimidazole Nucleosides,”J. Med. Chem., vol. 25, No. 11, pp. 1339-1342 (1982).
Amada Hideaki
Asanuma Hajime
Kakinuma Hiroyuki
Sato Masakazu
Tsuchiya Yuko
Lewis Patrick T
Sughrue & Mion, PLLC
Taisho Pharmaceutical Co. Ltd.
LandOfFree
Heteroaryl 5-thio-β-D-glucopyranoside derivatives and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heteroaryl 5-thio-β-D-glucopyranoside derivatives and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heteroaryl 5-thio-β-D-glucopyranoside derivatives and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4012547